Dodge & Cox’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.44B	Sell	4,458,238 -138,120	-3%	-$106M	1.89%	12
2025 Q4	$3.55B	Buy	4,596,358 +45,513	+1%	+$30.9M	1.92%	10
2025 Q3	$2.56B	Buy	4,550,845 +724,562	+19%	+$410M	1.38%	29
2025 Q2	$2.01B	Buy	3,826,283 +1,502,198	+65%	+$838M	1.13%	35
2025 Q1	$1.47B	Buy	2,324,085 +2,769	+0.1%	+$1.9M	0.84%	46
2024 Q4	$1.65B	Buy	2,321,316 +9,381	+0.4%	+$7.87M	0.96%	41
2024 Q3	$2.43B	Sell	2,311,935 -3,751	-0.2%	-$4.17M	1.37%	27
2024 Q2	$2.43B	Sell	2,315,686 -44,178	-2%	-$42.8M	1.46%	24
2024 Q1	$2.27B	Sell	2,359,864 -7,816	-0.3%	-$7.43M	1.32%	29
2023 Q4	$2.08B	Sell	2,367,680 -5,318	-0.2%	-$4.38M	1.32%	28
2023 Q3	$1.95B	Sell	2,372,998 -21,357	-0.9%	-$16.8M	1.32%	26
2023 Q2	$1.72B	Buy	2,394,355 +9,654	+0.4%	+$7.44M	1.15%	28
2023 Q1	$1.96B	Buy	2,384,701 +161,642	+7%	+$122M	1.34%	25
2022 Q4	$1.6B	Sell	2,223,059 -63,450	-3%	-$46.8M	1.1%	33
2022 Q3	$1.58B	Buy	2,286,509 +21,175	+0.9%	+$13.3M	1.19%	31
2022 Q2	$1.34B	Buy	2,265,334 +28,271	+1%	+$18.4M	0.93%	44
2022 Q1	$1.56B	Buy	2,237,063 +1,957,941	+701%	+$1.24B	0.95%	42
2021 Q4	$176M	Buy	+279,122	New	+$172M	0.11%	85